This Masterclass Series is sponsored by the State Government of Victoria, Department of Jobs, Precincts and Regions.
The success of early-stage biopharma hinges not only on the efficacy and safety of a product, but on the company’s ability to achieve product-market-fit (PMF) and ultimately, attract investment. The path to PMF is contingent not only on the science behind a product, but on the art of achieving success in market.
Business and investment strategy is critical to success. Developing a robust strategy can be complex, expensive and time-consuming, and if not completed efficiently, can lead to costly delays, loss of investor confidence and even failure.
Advancing Global Business Strategy for BioPharma is a customised program designed to support early-stage biopharma executives. Participants will gain valuable skills and methodologies to develop effective business and investment strategies, optimise investor interest and accelerate their path to market.
Masterclass 1 | Creating a Value Story for Your Product | Commences 22 March 2022
Leading industry experts
Biointelect Pty Ltd is a strategic planning and commercialisation consultancy supporting early stage biotech to develop and drive strategy, identify and evaluate new business opportunities and find the right partners. Read more about Biointelect
Masterclass components
This Masterclass has three components (delivered in-person):
Masterclass 2 | The Art of Capital Raising: Negotiating the Investment Landscape | Commences 24 May 2022
Leading industry experts
Gadens is a leading provider of legal services and recognised as a leading firm for advisory, transaction and disputes. They advise early stage companies through to large multinational pharmaceutical and medical device companies, as well as universities and research institutes. Read more about Gadens
Support from Dr Christine Brennan, Ph.D., Managing Director Vertex Ventures HC (USA).
Masterclass components
This Masterclass has three components (delivered in-person):